Arthur Tzianabos, President & CEO at Homology Medicines, Inc. (FIXX), sold 12,500 shares at $17.39 ($217K) on 2019-10-01, disclosed to the SEC on 2019-10-02.
Open-market sale of $217k FIXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.39 | 12,400 | $216K | 99.2% |
| 2 | $18.23 | 100 | $2K | 0.8% |
| Total | $17.40 avg | 12,500 | $217K | 100% |
| Filing → |
| FIXX | SELL | 2024-02-15 | $7K | — | Filing → |
| FIXX | SELL | 2023-01-11 | $15K | — | Filing → |
| FIXX | SELL | 2022-01-12 | $20K | — | Filing → |